10/07/2015 - 11:20am

Camber Pharmaceuticals has rolled out its generic version of Mirapex and Plavix.

10/07/2015 - 10:32am

More than 260,000 pharmacists have been trained to provide immunization services through APhA, association says. 

10/05/2015 - 11:43am

The Generic Pharceutical Association’s CEO and President Chip Davis offered his recommendations for the Trans-Pacific Partnership. 

10/05/2015 - 11:40am

The New York Times outlines the impact price increases of Valeant Pharmaceutical's Cuprimine has on one family, juxtaposing Valeant's pharmaceutical business model against the threat of government action. “Cuprimine is just one of many Valeant drugs whose prices have spiked as part of the company’s concerted strategy, which has richly rewarded its investors and made it one of Wall Street’s most popular health stocks,” the article said. “But Valeant’s habit of buying up existing drugs and raising prices aggressively, rather than trying to develop new drugs, has also drawn the ire of lawmakers and helped stoke public outrage against the growing trend of higher and higher drug prices imposed by big drug companies.” (New York Times)



10/05/2015 - 11:22am

Overall, 22% of consumers who are enabling their health management through technology in 2015 vs. 13% two years ago.

10/01/2015 - 2:40pm

Tussionex has launched its generic of Tussionex, taking over marketing and distribution from Par Pharmaceuticals after Par's rights to the drug expire. 

10/01/2015 - 10:34am

Sanofi announced Thursday that it had launched its generic of Arava (lefluniomide) tablets through its U.S. generics division Winthrop.

09/28/2015 - 2:25pm

Aurobindo’s latest generic is of Pfizer’s Lopid, which treats high cholesterol alongside diet and exercise.

09/28/2015 - 1:24pm

As a result of the $8.05 billion acquisition, Endo has adjusted its guidance for FY2015.